Search

Alder Plans for FDA Filing After Migraine Drug Posts Strong Results

ALDER PLANS FOR FDA FILING AFTER MIGRAINE DRUG POSTS STRONG RESULTS

Alder Therapeutics' migraine-prevention drug hit its main goal in a late-stage study, and the drug developer these early results keep...

 
 
 
First Video Game Therapy Heads to FDA As Akili Touts ADHD Study Win

FIRST VIDEO GAME THERAPY HEADS TO FDA AS AKILI TOUTS ADHD STUDY WIN

For the first time ever, a mobile video game used to assess and treat a disease is headed for an FDA review. Akili Interactive Labs,...

 
 
 
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More

BIO ROUNDUP: MIGRAINE DATA, CANCER DRUG COMBOS, AZAR HEARING & MORE

A pair of migraine drugs made a splash in biotech news this week with published data suggesting that they can reduce the frequency...

 
 
 

ATLAS, AMGEN, LILLY BACK KYMERA'S $30M SERIES A

Atlas-incubated Kymera Therapeutics has gotten off a $30 million series A and taken on Pierre Fabre's R&D head as its new chief.

 
 
 
Injection may help people lose 10% of their weight

INJECTION MAY HELP PEOPLE LOSE 10% OF THEIR WEIGHT

Researchers based in Amgen's LA office also found that when given to monkeys, the injection improved their blood glucose levels, which...

Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More

BIO ROUNDUP: NOBEL PURSUIT, FUNDRAISING FRUIT, A RHYTHMIC IPO & MORE

The 2017 Nobel Prizes with a biomedical bent were announced this week. Three researchers shared the physiology and medicine prize for...

 
 
 
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More

BIO ROUNDUP: GRAHAM-CASSIDY, AXOVANT FAIL, SPRINGWORKS LAUNCHES & MORE

After drug pricing, count drug shortages among the hot button issues sparking patient ire. Last year, the FDA says, 23 drug shortages...

Eyeing a Comeback, Arrowhead Bets on New RNAi Delivery Tool

EYEING A COMEBACK, ARROWHEAD BETS ON NEW RNAI DELIVERY TOOL

Following a series of setbacks late last year, Arrowhead Pharmaceuticals, one of the companies trying to develop drugs using RNA interference,...

 
 
 
Bio Roundup: Phase 3 Fails, Shkreli Jailed, Moderna Flip-Flops & More

BIO ROUNDUP: PHASE 3 FAILS, SHKRELI JAILED, MODERNA FLIP-FLOPS & MORE

It was a week of realignments. President Trump, who used to be known as “The Donald” but now goes by “ Amnesty Don ,” kept up the parlay-voo...

 
 
 
 
 
 

AMGEN ANNOUNCES 2017 THIRD QUARTER DIVIDEND

Life Sciences Jobs ...

SAFETY ISSUES FORCE THE FDA TO TURN DOWN AMGEN, UCB SA'S BONE DRUG

Life Sciences Jobs ...

 
 
 

SERES THERAPEUTICS STRENGTHENS BOARD OF DIRECTORS WITH APPOINTMENT OF M.D., FORMER AMGEN CHIEF MEDICAL OFFICER

Life Sciences Jobs ...

AMGEN RECEIVES POSITIVE OPINION TO EXPAND USE OF MIMPARA FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN CERTAIN CHILDREN WITH END-STAGE RENAL DISEASE ON DIALYSIS

Life Sciences Jobs ...